Torrent Pharmaceuticals, the flagship company of the Torrent Group, Ahmedabad, is leading its next phase of growth through innovative chronic therapies and expansion in the emerging areas with high growth such as weight loss treatments.
The Oncology Subject Expert Committee (SEC), which is a part of the Central Drugs Standard Control Organisation (CDSCO), has advised that MSN Laboratories Pvt. Ltd. be given the green light to produce and sell Abiraterone Acetate
Roche’s experimental multiple sclerosis (MS) drug fenebrutinib has reached a major milestone, meeting its main goal in one of two late-stage trials for relapsing MS. The treatment sharply reduced annualised relapse rates over 96 weeks compared with..
The U.S. Food and Drug Administration (FDA) has granted final approval to Alembic Pharmaceuticals Limited for its Abbreviated New Drug Application (ANDA) of Sumatriptan Injection which represents a major achievement for the company in the...
Glenmark Specialty S.A.,a subsidiary of Glenmark Pharmaceuticals Ltd. that is fully owned, announced that its innovative nasal spray for allergic rhinitis, Ryaltris Compound Nasal Spray (GSP 301 NS), has received approval from China
Marksans Pharma experienced an increase of 1.94%, reaching Rs 186.30, following the announcement that it received zero observations during a current Good Manufacturing Practice (cGMP) inspection conducted by the US Food and Drug Administration
Novo Nordisk India partners with Emcure Pharma to launch Poviztra, expanding access to semaglutide 2.4 mg for safe, effective weight loss across India.
The Johnson & Johnson's (J&J) CAPLYTA (lumateperone) product has been given a green light by the U.S. Food and Drug Administration (USFDA) to be used as adjunctive therapy with antidepressants for adult major depressive disorder
.png "Pfizer Beats Novo Nordisk in $10 Billion Metsera Deal")
Pfizer has clinched a major victory in the race for next-generation obesity treatments, signing a deal to acquire development-stage drugmaker Metsera Inc. after outbidding rival Novo Nordisk, the maker of Ozempic and Wegovy...
The transition from volume-led growth to value- and innovation-led expansion is currently the defining trend of the Indian pharmaceutical business
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")